Bovine-based Collagen for Biomedical Applications Market is predicted to reach USD 2.97 billion at a CAGR of 10.60% during the forecast period 2023-2032

Market Research Future (MRFR) has published on the “Global Bovine-based Collagen for Biomedical Applications Market”.

The Bovine-based Collagen for Biomedical Applications Market is estimated to register a CAGR of 10.60% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Bovine-based Collagen for Biomedical Applications Market— Rousselot, BBI Solution, Foodmate Co. Ltd, Botiss Biomaterials GmbH, Medtronic PLC, Kyeron, Collagen Matrix Inc., Collagen Solutions PLC, Titan Biotech, Symatese, DCP Ingredients (DCP B.V.), and LAPI GELATINE S.p.a.

Bovine-based Collagen for Biomedical Applications Market Highlights

The global Bovine-based Collagen for Biomedical Applications Market is accounted to register a CAGR of 10.60% during the forecast period and is estimated to reach USD 2.97 billion by 2032.

Collagen products have long been recognized to be beneficial to human health, particularly in older adults. The effects of collagen therapy have been studied in clinical research on rheumatoid arthritis, osteoarthritis, sarcopenia, wound healing, dental therapy, and acid reflux. The infectious, lethal disease known as "mad cow disease," or bovine spongiform encephalopathy (BSE), attacks the central nervous system of adult cattle. Thousands of cattle have been tested for BSE by the US Department of Agriculture (USDA). The infectious agent thought to cause mad cow disease is thought to be a prion protein, which is normally found on cell surfaces.

Segment Analysis

The global Bovine-based Collagen for Biomedical Applications Market has been segmented based on Application.

On the basis of Application, the market is segmented into Bone Graft Substitutes, Collagen-based Scaffolds, Hemostats, Skin Substitutes, Cartilage Repairs, and Others. The Bone Graft Substitutes segment was attributed to holding the largest market share in 2023. The rising incidence of disorders associated with the bones, such as osteoporosis and arthritis, is driving the expansion of this market.

Regional Analysis

The global Bovine-based Collagen for Biomedical Applications market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Bovine-based Collagen for Biomedical Applications Market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Bovine-based Collagen for Biomedical Applications Market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Bovine-based Collagen for Biomedical Applications Market comprises the Middle East, Africa, and Latin America.

The largest market share for biomedical services was maintained by the North American regional sector. This is due to elements such as the increased prevalence of bone-related illnesses, the aging population, improved healthcare facilities, public knowledge of new technologies among stakeholders in the healthcare sector, and the concentration of market competitors in the area. The region's high rate of both acute and chronic wounds is said to be driving research into regenerative medicine and wound healing using collagen derived from cows, which will boost the region's growth.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Bovine-based Collagen for Biomedical Applications Market Trends Report

Moreover, the Europe market has been persistently growing over the forecast period. Germany's market is expected to grow as a result of crucial elements, including the carriers' strategic efforts and the growing need for collagen derived from cows' milk to treat orthopedic conditions. In November 2021, for example, the age- and sex-specific prevalence of psoriatic arthritis (PsA) showed an upward trend with increasing age until it reached a peak shortly before the age of 60 and then began to decline, according to an article titled "Risk of psoriatic osteoarthritis depending on age: analysis of data from 65 million people on mandatory insurance in Germany.

Additionally, the Asia-Pacific Bovine-based Collagen for Biomedical Applications Market is anticipated to expand between 2024 and 2032 at the quickest CAGR owing to a rise in product launches, growth in regenerative medicine research and development, and an expansion of orthopedic and dental operations. China is expected to have a rise in knee and hip replacement procedures during the projected period as a result of factors such as the aging population and increasing incidence of osteoarthritis.

Furthermore, the rest of the world's Bovine-based Collagen for Biomedical Applications Market is divided into the Middle East, Africa, and Latin America. The growing requirement for orthopedic and dental operations, the growing need for bovine-based collagen to treat various ailments, and the continuous research and development for wound-healing and regenerative therapies are the main drivers driving the market's expansion.

Key Findings of the Study

• The global Bovine-based Collagen for Biomedical Applications Market is expected to reach USD 2.97 billion by 2032, at a CAGR of 10.60% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market owing to a rise in product launches, a growth in regenerative medicine research and development, and an expansion of orthopedic and dental operations.


• Based on Application, the Bone Graft Substitutes segment was attributed to holding the largest market in 2023.


• Rousselot, BBI Solution, Foodmate Co. Ltd, Botiss Biomaterials GmbH, Medtronic PLC, Kyeron, Collagen Matrix Inc., Collagen Solutions PLC, Titan Biotech, Symatese, DCP Ingredients (DCP B.V.), and LAPI GELATINE S.p.a are the key market players.a